You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1928005 |
---|---|
Category | Antibodies |
Description | Affinity Purified Rabbit Polyclonal Antibody (Pab) |
Species/Host | Rabbit |
Clonality | Polyclonal |
Clone Number | RB23250 |
Tested applications | FC, IHC-P, WB |
Predicted Reactivity | Mouse, Other |
Reactivity | Human |
Isotype | Rabbit IgG |
Antibody Type | Primary Antibody |
Dilution range | WB: 1:1000, IHC-P: 1:50~100, IHC-P: 1:100, FC: 1:10~50 |
Form/Appearance | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Conjugation | Unconjugated |
MW | 13916 Da |
Target | This SNRPD3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 99-126 amino acids from the C-terminal region of human SNRPD3. |
UniProt ID | P62318 |
NCBI | NP_004166.1, NP_001265585.1 |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
Alternative names | Small nuclear ribonucleoprotein Sm D3, Sm-D3, snRN Read more... |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Formalin-fixed and paraffin-embedded H.kidney tissue reacted with SNRPD3 Antibody (C-term).
Western blot analysis of SNRPD3 Antibody (C-term) in MCF-7, Jurkat cell line lysates (35 ug/lane). SNRPD3 (arrow) was detected using the purified Pab.
SNRPD3 Antibody (C-term) flow cytometric analysis of MCF-7 cells (bottom histogram) compared to a negative control cell (top histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.
SNRPD3 Antibody (C-term) IHC analysis in formalin fixed and paraffin embedded human lung carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the SNRPD3 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.